ABSTRACT OBJECTIVES This study sought to determine the effect of radial access on outcomes in women undergoing percutaneous coronary intervention (PCI) using a registry-based randomized trial.
I
schemic heart disease is a leading cause of death among women. Although currently recommended treatment strategies such as antithrombotic therapy and revascularization improve outcomes in patients with unstable angina and myocardial infarction (1), they have been studied in predominantly male populations. Compared with men, women are at increased risk of adverse outcomes after acute coronary syndrome (2) and invasive procedures such as percutaneous coronary intervention (PCI) (3) . They are also at increased risk of bleeding complications of both medical therapies for acute coronary syndrome (ACS) (4) and femoral artery access for PCI (5) .
Bleeding is the most common complication of PCI and is associated with increased short-and longterm morbidity, mortality, and costs (6, 7) . Using the radial artery as the access site for PCI significantly decreases bleeding and access site complications compared with the traditional femoral artery approach (8) , but in contemporary clinical practice, women are much less likely to undergo transradial PCI (9) .
Women presenting for cardiac catheterization present a unique challenge because, although they are at higher risk of femoral arterial access site bleeding, radial artery access may not be feasible.
Compared with males, females have smaller radial arteries (10) that may be more prone to spasm, which is a major cause of radial procedure failure (11) Two patient cohorts were pre-specified: the total randomized cohort and the PCI cohort. The total randomized cohort included all patients randomized regardless of whether they underwent PCI. The PCI cohort was a subgroup of the total randomized cohort and included patients who underwent PCI as defined in the following. The primary analysis of efficacy and feasibility was performed in the PCI cohort, and a sensitivity analysis was performed in the total randomized cohort.
RANDOMIZATION. After providing written informed consent, patients were randomized 1:1 to either radial or femoral arterial access. Randomization was performed via an online randomization module incorporated into the registry trial database. Vascular complications included a composite of arteriovenous fistula, arterial pseudoaneurysm, or arterial occlusion requiring intervention. Access site crossover was defined as the inability to complete the procedure from the assigned arterial access site,
Rao et al. Two pre-specified subgroup analyses for the primary efficacy endpoint were performed: ACS versus non-ACS in the PCI cohort and quartiles of site radial volume in the total randomized cohort. A post-hoc interaction for the primary efficacy endpoint was examined in the total randomized cohort between patients who underwent PCI and those who did not.
We also performed an analysis according to the access site used to complete the procedure (as treated analysis) in both the randomized and PCI cohorts.
Exploratory comparisons between the radial and femoral groups were conducted for 72 h or hospital discharge bleeding events using the Thrombolysis In Myocardial Infarction (19) and ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) (20) trial definitions, as well as bleeding and vascular activated sites enrolled at least 10 patients. Of the total randomized cohort, 893 were assigned to radial access and 894 were assigned to femoral access; of the PCI cohort, 345 and 346 were assigned to radial and femoral access, respectively (Fig. 1) . Follow-up for the primary endpoints was available for 99.9% of the PCI cohort and 99.3% of the total randomized cohort. Baseline characteristics of the total randomized and PCI cohorts are shown in Tables 1 and 2 .
There were no significant differences between the randomized groups in either cohort. The majority of procedures were performed for non-ST-segment elevation ACS. Unfractionated heparin was given during the diagnostic catheterization to 65.9% of the Women undergoing urgent or elective PCI or coronary angiography with the possibility of PCI were randomized to either radial or femoral arterial access. Shown are the number of patients in each group, the number of patients in each group who underwent PCI, and the number of patients assessed at 30 days for the secondary endpoint.
FFR ¼ fractional flow reserve; IVUS ¼ intravascular ultrasound; OCT ¼ optical coherence tomography; PCI ¼ percutaneous coronary intervention.
Radial vs. Femoral Access in Women patients assigned to radial access and 25.7% of the patients assigned to femoral access in the PCI cohort.
Bivalirudin was used as the anticoagulant during PCI for 59.1% and 65.8% of procedures in the radial and femoral groups, respectively. Vascular closure devices were used for hemostasis in 65.5% of the patients assigned to femoral access.
The primary efficacy and feasibility outcomes and secondary outcomes for the PCI and total randomized cohorts are shown in Table 3 . The rate of BARC type 2, 3, or 5 bleeding or vascular complications requiring intervention in the femoral arm of the PCI cohort, which was the primary analysis cohort, was lower than predicted (2.9%). Compared with femoral access, radial access reduced the primary efficacy endpoint in this cohort by 60% in the PCI cohort, which did not reach statistical significance.
There were no significant interactions noted in the pre-specified subgroups of ACS versus non-ACS in the PCI cohort (Fig. 2) . In the total randomized cohort, radial access significantly reduced bleeding and vascular complications by 70% compared with femoral access. There was no significant interaction by volume of radial procedures performed at participating sites; similarly, the post-hoc analysis of the interaction between patients who underwent PCI and those who did not was also not significant (p ¼ 0.58) (Fig. 2) . With respect to the primary feasibility endpoint, the rate of conversion to femoral access from radial access was significantly higher than the rate of conversion to radial access from femoral access in both cohorts. Only 1 patient, who was assigned to femoral access, did not have her diagnostic catheterization procedure successfully completed from either access site. The major reason for conversion from radial to femoral access was radial artery spasm occurring in 42.9% of crossover patients in the PCI cohort and 43.6% of crossover patients in the total randomized cohort. Other reasons for access site crossover are listed in the Online Appendix, as are the primary efficacy results in the as-treated analysis in both cohorts, which were similar to the intentionto-treat results.
Secondary outcomes of procedure duration and total radiation dose were not statistically different between the radial and femoral access groups (Table 4) ; the mean total contrast volume was significantly higher among patients assigned to femoral access. Thirty-day follow-up was available for 582 patients in the PCI cohort (84.2%). The rate of 30-day death, vascular complications, or unplanned revascularization was not significantly different between the 2 arms. Exploratory analyses using different bleeding definitions also showed no significant differences in either the total randomized or PCI cohort (Table 5) . At 30-day follow-up, 71.9% of patients assigned to the radial approach preferred radial access for their next procedure; 23.5% of patients There is reason to believe that women may respond to treatment strategies differently from men, and it is clear that women are at significantly higher risk of bleeding with antithrombotic therapy for ACS and after PCI (18) . Such bleeding complications often occur at the vascular access site and are associated with subsequent adverse events such as myocardial infarction, stroke, stent thrombosis, and even death (26) . The majority of PCI procedures in the United States are performed via femoral artery access (9) .
The femoral artery is large and readily accommodates PCI equipment, and spasm is rare. On the other hand, hemostasis after femoral access requires the effect of procedural anticoagulation to wane, thus necessitating prolonged post-PCI bed rest. In addition, the femoral artery is deeply situated, particularly in overweight or obese patients, can have atherosclerotic narrowing, needs relatively intense manual compression to achieve hemostasis after PCI, and is difficult to monitor for occult bleeding such as retroperitoneal hematomas, which are associated with increased morbidity and mortality (26) .
Several strategies have emerged to reduce the risk of post-PCI bleeding and are termed "bleeding avoidance strategies," which include the direct thrombin inhibitor bivalirudin, potentially the use of vascular closure devices, and radial access (27) . In observational studies, radial artery access is associated with a large reduction in access site bleeding and major vascular complications compared with femoral access (8) . The radial artery is superficial and readily compressible and rarely has atherosclerosis. In patients at high risk of bleeding, such as those with STEMI, radial access for primary PCI may also reduce mortality by reducing major bleeding events (28). Rao et al.
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However, its small caliber can exclude the use of large-bore catheters in some patients, and arterial spasm is a major cause of radial access site crossover necessitating conversion to the femoral approach (11) . 
